An Active Presence on Capitol Hill

Recognizing the need for more research into causes and treatments of functional gastrointestinal and motility disorders,IFFGD has provided oral and/or written testimony to Congressional subcommittees many times over the years.congressional testimony

Each fiscal year (FY), Congress decides how much funding to provide federally supported medical research initiatives, what areas of research should be prioritized, and how much funding should be committed towards new drug approval and the monitoring of current treatment options.Whenever appropriate, IFFGD offers testimony which expresses the needs of functional GI and motility disorder patients and urges additional resources for the National Institutes of Health (NIH) and Food & Drug Administration (FDA).

IFFGD has presented the needs of the digestive health community to both the Senate and the House Appropriations Subcommittees on Labor, Health & Human Services, Education and Related Agencies, as well as the Senate Appropriations Subcommittee on Defense.

April 29, 2015

IFFGD submitted written testimony to the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies regarding Fiscal Year 2016 appropriations for the National Institutes of Health (NIH). Read the full testimony here..

June 6, 2012

IFFGD provided oral testimony regarding Fiscal Year 2013 appropriations for the Department of Defense (DOD) Gulf War Illness Research Program to the U.S Senate Appropriations Committee, Subcommittee On Defense. Read the full testimony here..

June 22, 2011

IFFGD presented oral testimony regarding Fiscal Year 2012 appropriations for the Department of Defense (DOD) Peer Reviewed Medical Research Program to the U.S. Senate Appropriations Committee, Subcommittee On Defense. View video or read the full testimony here..

May 1, 2009

IFFGD submitted written testimony to the House Committee on Appropriations; Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding Fiscal Year 2010 appropriations for the National Institutes of Health. Read the full testimony here..

April 28, 2008

IFFGD provided written testimony regarding Fiscal Year 2009 appropriations for the National Institutes of Health to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies. Read the full testimony here..

March 27, 2007

IFFGD provided oral testimony regarding Fiscal Year 2008 Funding for Functional Gastrointestinal and Motility Disorders Research before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here..

May 19, 2006

IFFGD presented oral testimony to both the U.S. Senate and U.S. House Appropriations Subcommittees on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2007 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here..

2005

IFFGD provided oral testimony before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2006 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here..

2004

IFFGD presented oral testimony regarding Fiscal Year 2005 Funding for Functional Gastrointestinal and Motility Disorders Research before the House Appropriations subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here..

May 7, 2003

IFFGD provided oral testimony before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2004 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here..

May 2, 2002

IFFGD presented oral testimony regarding Fiscal Year 2003 Irritable Bowel Syndrome Research to the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here..

About IFFGD
Leadership
Nancy J. Norton, IFFGD President
Advisory Board
Board of Directors
Editorial Board Members
Our Mission
Awareness Activities & Accomplishments
Public Education & Awareness
Professional Education & Awareness
Year in Review
-2014
-2012/2013
Advocacy Activities
Legislative Successes
FGIMD Act (Functional Gastrointestinal and Motility Disorders Research Enhancement Act)
Congressional Testimony
FISCAL YEAR 2016
FISCAL YEAR 2013
FISCAL YEAR 2012
FISCAL YEAR 2010
FISCAL YEAR 2009
FISCAL YEAR 2008
FISCAL YEAR 2007
FISCAL YEAR 2006
FISCAL YEAR 2005
FISCAL YEAR 2004
FISCAL YEAR 2003
FDA and Other Testimony
Written Comments to FDA June 29, 2015
Oral Comments to FDA May 11, 2015
Comments to FDA July 16th, 2014
Written Comments to Noridian October 24, 2013
Testimony to FDA October 25, 2012
Testimony to FDA September 12, 2012
Testimony to FDA December 13, 2011
Testimony to FDA December 2, 2010
Testimony to FDA April 23, 2002
Comments to FDA November 9, 2000
Testimony to FDA June 27, 2000
Testimony to FDA June 26, 2000
Capital Hill Advocacy Day
Research
IFFGD Research Awards
IFFGD Symposium reports
2013 Professional Symposium
10th Symposium Report
10th Symposium Audio Recordings
More from the 10th Symposium on FGIDs
2011 Professional Symposium
9th Symposium Report
2009 Professional Symposium
2007 Professional Symposium
7th Symposium Report
2005 Professional Symposium
6th Symposium Report
2003 Professional Symposium
5th Symposium Report
2002 Conference - Advancing the Treatment of Incontinence
Funding
Corporate Support
Our Research Funding Needs
IFFGD Standards for Collaboration
Industry Council
Supporters
Code of Ethics
Contact Us
Media Contact
Donation

Advocacy Effort

capital hill day s

Involvement in Shaping National Health Care Policy

IFFGD is a voice on Capital Hill working with the digestive health community.

Advocacy Activities, Legislative & Regulatory

Legislative Successes

Congressional Testimony